[go: up one dir, main page]

TW201713316A - 經皮吸收型貼付劑 - Google Patents

經皮吸收型貼付劑 Download PDF

Info

Publication number
TW201713316A
TW201713316A TW105121744A TW105121744A TW201713316A TW 201713316 A TW201713316 A TW 201713316A TW 105121744 A TW105121744 A TW 105121744A TW 105121744 A TW105121744 A TW 105121744A TW 201713316 A TW201713316 A TW 201713316A
Authority
TW
Taiwan
Prior art keywords
drug
absorption type
type patch
solifenacin
containing layer
Prior art date
Application number
TW105121744A
Other languages
English (en)
Chinese (zh)
Inventor
Toru Koga
Kazuo Yamane
Original Assignee
Oji Holdings Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oji Holdings Corp filed Critical Oji Holdings Corp
Publication of TW201713316A publication Critical patent/TW201713316A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
TW105121744A 2015-07-08 2016-07-11 經皮吸收型貼付劑 TW201713316A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2015137255 2015-07-08
JP2015210347 2015-10-27

Publications (1)

Publication Number Publication Date
TW201713316A true TW201713316A (zh) 2017-04-16

Family

ID=57685304

Family Applications (1)

Application Number Title Priority Date Filing Date
TW105121744A TW201713316A (zh) 2015-07-08 2016-07-11 經皮吸收型貼付劑

Country Status (3)

Country Link
JP (1) JP6729584B2 (ja)
TW (1) TW201713316A (ja)
WO (1) WO2017006974A1 (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019201755A1 (en) * 2018-04-17 2019-10-24 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system for the transdermal administration of solifenacin

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113476459A (zh) * 2021-08-16 2021-10-08 浙江鼎泰药业股份有限公司 一种高活性缓释止痛贴及其制备工艺

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02174716A (ja) * 1988-09-05 1990-07-06 Takeda Chem Ind Ltd 経皮用製剤
WO2005077364A1 (ja) * 2004-02-18 2005-08-25 Yamanouchi Pharmaceutical Co., Ltd. ソリフェナシンの経皮投与製剤およびその経皮透過改善方法
JP5403948B2 (ja) * 2007-06-07 2014-01-29 久光製薬株式会社 メマンチン含有経皮吸収製剤
WO2009145177A1 (ja) * 2008-05-30 2009-12-03 日東電工株式会社 ドネペジル含有貼付製剤およびその包装体
US20150030666A1 (en) * 2011-11-28 2015-01-29 KM Transderm Ltd. Adhesive skin patch
JP5415645B1 (ja) * 2013-06-28 2014-02-12 久光製薬株式会社 貼付剤の製造方法、貼付剤及び包装体

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019201755A1 (en) * 2018-04-17 2019-10-24 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system for the transdermal administration of solifenacin
CN112040936A (zh) * 2018-04-17 2020-12-04 罗曼治疗系统股份公司 用于透皮施用索利那新的透皮治疗系统
CN112040936B (zh) * 2018-04-17 2024-07-23 罗曼治疗系统股份公司 用于透皮施用索利那新的透皮治疗系统
US12121616B2 (en) 2018-04-17 2024-10-22 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system for the transdermal administration of solifenacin

Also Published As

Publication number Publication date
JPWO2017006974A1 (ja) 2018-04-19
WO2017006974A1 (ja) 2017-01-12
JP6729584B2 (ja) 2020-07-22

Similar Documents

Publication Publication Date Title
KR101734602B1 (ko) 도네페질 함유 경피 흡수형 제제
JP5073124B2 (ja) ノルアドレナリン作動性・特異的セロトニン作動性抗うつ薬含有経皮吸収型貼付製剤
US20080138388A1 (en) Transdermal Absorption Patch
JP5403948B2 (ja) メマンチン含有経皮吸収製剤
JP5795264B2 (ja) 抗認知症薬物の経皮吸収製剤
TWI542368B (zh) 含有血清素受體拮抗劑之貼劑
US9457012B2 (en) Transdermal absorption preparation
JP6459148B2 (ja) 経皮吸収型製剤
TW201713316A (zh) 經皮吸收型貼付劑
WO2010113225A1 (en) Riluzole-containing transdermal patch
WO2016080533A1 (ja) 経皮吸収型製剤
JP6695571B2 (ja) 経皮吸収型製剤
US20170014417A1 (en) Pharmaceutical administration system for the transdermal application of vardenafil
JP6675589B2 (ja) 経皮吸収型製剤
JP6512905B2 (ja) フェンタニル含有貼付剤
WO2005102306A1 (ja) 消炎鎮痛貼付剤
EP1611882B1 (en) Adhesive patch
WO2013183407A1 (ja) ミルタザピン含有経皮吸収型貼付製剤
WO2017057541A1 (ja) 経皮吸収型製剤
JP2017007994A (ja) 経皮吸収型製剤
TW201332592A (zh) 經皮吸收型製劑
TW202440102A (zh) 含多奈哌齊之經皮吸收製劑
JP2016216384A (ja) 経皮吸収型製剤